Journal article
Idiopathic pulmonary fibrosis
The New England journal of medicine, Vol.345(7), pp.517-525
2001
DOI: 10.1056/NEJMra003200
PMID: 11519507
Abstract
Idiopathic pulmonary fibrosis is a rapidly progressive illness of unknown cause characterized by sequential acute lung injury with subsequent scarring and end-stage lung disease. Treatment at present remains largely supportive, with evidence that patients' satisfaction and survival may be improved by referral to centers specializing in the evaluation of interstitial lung diseases. Although no drug therapy has clearly been demonstrated to benefit patients with idiopathic pulmonary fibrosis, a number of novel investigational agents hold promise for future study. Given the poor prognosis associated with idiopathic pulmonary fibrosis, patients should be referred to regional centers of expertise for enrollment in therapeutic clinical trials or for lung transplantation.
Details
- Title: Subtitle
- Idiopathic pulmonary fibrosis
- Creators
- Thomas J GROSS - Division of Pulmonary, Critical Care, and Occupational Medicine, Department of Internal Medicine, University of Iowa College of Medicine and Veterans Affairs Medical Center, Iowa City, United StatesGary W HUNNINGHAKE - Division of Pulmonary, Critical Care, and Occupational Medicine, Department of Internal Medicine, University of Iowa College of Medicine and Veterans Affairs Medical Center, Iowa City, United States
- Resource Type
- Journal article
- Publication Details
- The New England journal of medicine, Vol.345(7), pp.517-525
- Publisher
- Massachusetts Medical Society
- DOI
- 10.1056/NEJMra003200
- PMID
- 11519507
- ISSN
- 0028-4793
- eISSN
- 1533-4406
- Language
- English
- Date published
- 2001
- Academic Unit
- Pulmonary, Critical Care, and Occupational Medicine; Internal Medicine
- Record Identifier
- 9984094490902771
Metrics
8 Record Views